≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Ménière disease

DOID EFO Endpoint Browser PheWeb

H8_MENIERE

endolymphatic hydrops: An accumulation of endolymph in the inner ear (labyrinth) leading to buildup of pressure and distortion of intralabyrinthine structures, such as cochlea and semicircular canals. It is characterized by sensorineural hearing loss; tinnitus; and sometimes vertigo.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H81.0
  • Hospital discharge: ICD-9 — 3860
  • Hospital discharge: ICD-8 — 38599
  • Cause of death: ICD-10 — H81.0
  • Cause of death: ICD-9 — 3860
  • Cause of death: ICD-8 — 38599

2 out of 7 registries used, show all original rules.

3773

4. Check minimum number of events

None

3773

5. Include endpoints

None

3773

6. Filter based on genotype QC (FinnGen only)

3773

Control definitions (FinnGen only)

Control exclude
H8_INNER

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H81
Name in latin
Morbus Ménière

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 26706 17134 9455
Only index persons 24436 15945 8491
Unadjusted period prevalence (%)
Whole population 0.41 0.49 0.26
Only index persons 0.50 0.59 0.32
Median age at first event (years)
Whole population 57.15 57.45 56.61
Only index persons 56.64 56.87 56.19

-FinnGen-

Key figures

All Female Male
Number of individuals 3773 2458 1315
Unadjusted period prevalence (%) 0.75 0.84 0.58
Median age at first event (years) 55.61 54.52 57.65

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
3413
Matched controls
34130
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N07CA01
ATC
betahistine; oral
100.9
323.0
2607
1061
H81.0
ICD-10 Finland
Ménière disease
13423.2
323.0
3225
42
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
15.2
323.0
631
503
Z01.1
ICD-10 Finland
Examination of ears and hearing
6.4
323.0
1156
2528
H81.3
ICD-10 Finland
Other peripheral vertigo
61.2
323.0
429
80
R42
ICD-10 Finland
Dizziness and giddiness
7.6
323.0
1791
4329
DFF00
NOMESCO Finland
Pure tone audiometry
6.6
284.1
827
1586
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
8.2
257.5
625
910
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
4.2
250.7
1191
3857
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
4.2
239.4
1123
3567
N05AB04
ATC
prochlorperazine; systemic, rectal
13.0
202.4
373
320
38599
ICD-8 Finland
Ménière's disease
+∞
202.1
192
*
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
12.7
171.5
318
274
UDC00
NOMESCO Finland
Ear microscopy
5.5
162.2
524
1083
DFF59
NOMESCO Finland
Other assessment of balance
36.7
155.3
201
58
3860A
ICD-9 Finland
Vertiginous syndromes and other disorders of vestibular system, Ménière's disease
+∞
154.3
147
*
C03EA02
ATC
trichlormethiazide and potassium-sparing agents; oral
11.4
148.1
289
275
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
18.1
117.8
187
109
H81.2
ICD-10 Finland
Vestibular neuronitis
66.8
116.7
135
21
DFF15
NOMESCO Finland
Speech audiometry
5.4
106.4
344
696
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
4.1
94.0
406
1100
H93.1
ICD-10 Finland
Tinnitus
4.0
88.4
381
1028
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
78.2
923
4776
H81.9
ICD-10 Finland
Disorder of vestibular function, unspecified
23.1
77.0
112
50
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
14.2
76.6
133
97
N17
ICPC
Vertigo/dizziness
2.9
75.9
535
2081
Z97.4
ICD-10 Finland
Presence of external hearing-aid
4.3
75.8
303
758
H02
ICPC
Hearing complaint
2.7
74.7
592
2470
DFF50
NOMESCO Finland
Electronystagmography
103.7
74.2
81
8
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
4.3
72.0
284
701
Z3229
NOMESCO Finland
Other healthcare associate professional
3.0
64.8
425
1568
H80.0
ICD-10 Finland
Otosclerosis involving oval window, nonobliterative
+∞
63.7
61
*
SPAT1043
SPAT
Audiometry
2.6
56.2
472
2011
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.5
54.3
491
2176
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
4.7
51.3
183
407
H02AB06
ATC
prednisolone; systemic
1.7
48.9
1639
11954
AA1AD
NOMESCO Finland
CT of head and brain
1.9
46.5
878
5311
R5120
NOMESCO Finland
Preparation of an aid
4.5
45.8
168
384
DFF40
NOMESCO Finland
Otoneurologic examination of vertigo
33.3
45.1
59
18
DC1AD
NOMESCO Finland
Temporalbone CT
9.8
44.8
92
96
H82
ICPC
Vertiginous syndrome
6.3
44.3
121
197
G44.2
ICD-10 Finland
Tension-type headache
2.2
42.7
492
2435
R51.80
ICD-10 Finland
Headache
2.1
38.7
499
2584
H91.9
ICD-10 Finland
Hearing loss, unspecified
3.3
38.5
206
654
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
4.3
37.5
145
350
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.6
37.3
295
1203
H80.9
ICD-10 Finland
Otosclerosis, unspecified
81.0
35.9
40
5
4173
FHL
Surgery on Saccus endolymphaticus
+∞
35.5
34
*
A02BC05
ATC
esomeprazole; systemic
1.6
34.5
1380
10212
DDA00
NOMESCO Finland
Stapedotomy
+∞
34.4
33
*
DFE00
NOMESCO Finland
Insertion of cochlear implant
20.7
34.4
51
25
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
33.9
741
4629
R01AD08
ATC
fluticasone; nasal
1.7
33.4
914
6102
DAX08
NOMESCO Finland
Fitting of hearing aid
3.0
33.0
201
698
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
5.1
32.7
105
209
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
3.6
31.9
150
431
R01AD09
ATC
mometasone; nasal
1.6
31.8
1400
10540
78050
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Vertigo
6.2
31.3
86
142
H29
ICPC
Ear symptom/complaint other
2.1
31.2
384
1941
R5140
NOMESCO Finland
Monitoring the use of the aid
2.2
31.2
360
1770
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
6.0
30.9
87
148
H80.1
ICD-10 Finland
Otosclerosis involving oval window, obliterative
+∞
27.1
26
*
M03BX02
ATC
tizanidine; oral
1.5
27.0
1935
15998
M25.5
ICD-10 Finland
Pain in joint
1.6
26.6
910
6377
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
26.0
775
5237
A02BC02
ATC
pantoprazole; systemic
1.5
25.8
2135
18100
A02BC03
ATC
lansoprazole; oral
1.5
25.8
995
7166
N02BE01
ATC
paracetamol; systemic, rectal
1.6
25.6
2858
25908
H13
ICPC
Plugged feeling ear
1.7
24.6
592
3766
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.2
24.6
267
1272
7804A
ICD-9 Finland
General symptoms, Dizziness and giddiness
4.9
24.5
82
172
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
24.4
1107
8244
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
23.8
887
6312
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
23.7
967
7022
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
23.5
960
6974
R11
ICD-10 Finland
Nausea and vomiting
2.1
23.1
271
1337
R06AE53
ATC
cyclizine, combinations; systemic
6.1
22.7
62
103
H81.8
ICD-10 Finland
Other disorders of vestibular function
40.3
22.6
28
7
R01BA52
ATC
pseudoephedrine, combinations; oral
1.5
22.6
995
7340
DFX00
NOMESCO Finland
Connecting cochlear implant
24.0
22.1
31
13
J01DB01
ATC
cefalexin; oral
1.5
22.1
2609
23352
M54.5
ICD-10 Finland
Low back pain
1.5
21.4
984
7303
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
5.4
21.3
64
120
DE2CM
NOMESCO Finland
Acoustic channel extensive MRI examination with 3 Tesla magnet
13.5
20.9
36
27
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
4.8
20.9
70
148
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.6
20.8
579
3814
H81.4
ICD-10 Finland
Vertigo of central origin
12.0
20.5
37
31
UJF32
NOMESCO Finland
Coloscopy
1.5
20.5
854
6200
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
20.3
1379
11035
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
20.0
618
4177
J01AA02
ATC
doxycycline; systemic
1.4
19.6
2546
22854
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
19.5
1860
15768
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
19.4
2087
18064
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.9
19.1
275
1471
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
19.1
507
3293
N03AX12
ATC
gabapentin; oral
1.6
19.1
495
3195
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
5.2
19.0
59
115
R03AC02
ATC
salbutamol; inhalant
1.4
18.9
1607
13318
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.8
18.6
325
1861
R06.0
ICD-10 Finland
Dyspnoea
1.5
18.6
789
5727
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.0
18.2
235
1205
J01CA04
ATC
amoxicillin; systemic
1.4
17.9
2506
22542
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
17.9
1540
12747
N06AX11
ATC
mirtazapine; oral
1.4
17.8
960
7303
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
17.8
1365
11076
DFA00
NOMESCO Finland
Saccotomy
+∞
17.7
17
*
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.7
17.4
367
2227
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.5
17.4
626
4375
M01AH05
ATC
etoricoxib; oral
1.4
17.3
1797
15311
C07AB07
ATC
bisoprolol; oral
1.4
16.9
1527
12698
SPAT1263
SPAT
Sampling
1.4
16.7
1292
10465
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.4
16.6
1645
13869
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.9
16.4
266
1486
J01FA06
ATC
roxithromycin; oral
1.4
16.3
1254
10133
M79.6
ICD-10 Finland
Pain in limb
1.4
16.3
1102
8711
K02.1
ICD-10 Finland
Caries of dentine
1.4
16.3
1583
13291
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
16.2
617
4360
J01MA02
ATC
ciprofloxacin; systemic
1.4
16.0
1198
9631
R01AD01
ATC
beclometasone; nasal
1.6
15.9
456
3013
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.4
15.9
76
225
J01FA10
ATC
azithromycin; systemic
1.3
15.8
1683
14307
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
15.4
1474
12305
H81
ICD-10 Finland
Disorders of vestibular function
10.1
15.4
30
30
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
15.3
1611
13649
H90.5
ICD-10 Finland
Sensorineural hearing loss, unspecified
4.3
15.2
56
132
XF404
NOMESCO Finland
Ambulatory ECG
1.7
15.2
308
1846
L01
ICPC
Neck symptom/complaint
1.6
15.2
408
2647
H53.1
ICD-10 Finland
Subjective visual disturbances
2.0
15.2
199
1027
M01AB05
ATC
diclofenac; systemic, rectal
1.3
15.0
2044
17987
R01AD12
ATC
fluticasone furoate; nasal
1.4
14.9
797
6020
J01DA01
ATC
[U] cefalexin; systemic
1.3
14.8
1936
16906
SPAT1153
SPAT
Removal of sutures
1.4
14.7
1002
7896
R53
ICD-10 Finland
Malaise and fatigue
1.5
14.7
605
4342
3861A
ICD-9 Finland
Vertiginous syndromes and other disorders of vestibular system, Other and unspecified peripheral vertigo
+∞
14.6
14
*
M01AE02
ATC
naproxen; oral, rectal
1.3
14.6
1702
14604
L03
ICPC
Low back symptom/complaint
1.4
14.4
710
5275
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
14.3
1372
11420
Z01.2
ICD-10 Finland
Dental examination
1.4
14.2
1155
9364
R03BA05
ATC
fluticasone; inhalant
1.5
14.1
532
3744
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
14.1
1280
10557
H04.10
ICD-10 Finland
Dry eye syndrome
1.7
14.0
301
1837
A98
ICPC
Health maint/preventive medicine
1.6
14.0
3137
29879
H92.0
ICD-10 Finland
Otalgia
2.2
14.0
149
707
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
13.9
513
3591
J01FA09
ATC
clarithromycin; systemic
1.4
13.9
909
7106
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
13.7
1055
8470
M01AX17
ATC
nimesulide; oral
1.4
13.6
798
6115
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
13.6
1103
8921
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.5
13.5
567
4072
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
13.5
474
3276
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.1
13.5
150
726
G43.9
ICD-10 Finland
Migraine, unspecified
2.1
13.4
146
697
N03AE01
ATC
clonazepam; systemic
1.9
13.4
186
984
J02AC01
ATC
fluconazole; systemic
1.3
13.4
1201
9863
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
13.3
1156
9444
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
13.3
410
2754
K30
ICD-10 Finland
Functional dyspepsia
1.7
13.2
307
1917
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
13.1
640
4735
N02AX02
ATC
tramadol; systemic, rectal
1.3
13.1
1283
10666
SPAT1097
SPAT
Recording of ECG
1.5
13.1
466
3231
J35.0
ICD-10 Finland
Chronic tonsillitis
2.3
13.0
119
527
A02BC01
ATC
omeprazole; systemic
1.4
13.0
855
6676
G47.3
ICD-10 Finland
Sleep apnoea
1.5
12.9
567
4108
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
12.9
787
6065
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
12.8
1267
10535
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.6
12.7
323
2065
3882A
ICD-9 Finland
Other disorders of ear, Sudden hearing loss, unspecified
9.7
12.7
25
26
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.3
12.6
1217
10083
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
12.5
1058
8585
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
12.5
736
5630
R20.2
ICD-10 Finland
Paraesthesia of skin
1.9
12.5
180
963
R55
ICD-10 Finland
Syncope and collapse
1.6
12.5
325
2092
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.3
12.3
1516
12977
R06AE07
ATC
cetirizine; oral
1.3
12.3
1267
10577
A02BC04
ATC
rabeprazole; oral
1.7
12.3
253
1526
Z97.8
ICD-10 Finland
Presence of other specified devices
7.1
12.3
29
41
KMAK
NOMESCO Finland
NA
1.3
12.2
1454
12382
N06AA09
ATC
amitriptyline; systemic
1.6
12.2
325
2102
SPAT1301
SPAT
No procedures
1.3
12.2
956
7666
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.8
12.1
213
1220
3891A
ICD-9 Finland
Deafness, Sensorineural deafness
15.9
12.1
19
12
N03AX16
ATC
pregabalin; oral
1.4
12.1
702
5354
DFF16
NOMESCO Finland
Speech-in-noise audiometry
12.4
12.1
21
17
C07AA05
ATC
propranolol; systemic
1.4
12.0
540
3926
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.7
12.0
233
1379
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
5.2
11.9
36
70
R07.3
ICD-10 Finland
Other chest pain
1.6
11.9
285
1795
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.6
11.9
288
1819
A02BA02
ATC
ranitidine; systemic
1.4
11.8
615
4597
L08
ICPC
Shoulder symptom/complaint
1.4
11.8
554
4061
WX110
NOMESCO Finland
Local anesthesy
1.3
11.7
2015
17993
M70.6
ICD-10 Finland
Trochanteric bursitis
1.5
11.6
393
2691
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
11.6
691
5292
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
11.5
694
5325
H83.1
ICD-10 Finland
Labyrinthine fistula
+∞
11.5
11
*
DE2CF
NOMESCO Finland
Acoustic channel extensive MRI examination with median intensity magnet
120.4
11.4
12
*
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
11.3
1143
9485
SGA01
NOMESCO Finland
Tooth opening as first aid
1.5
11.3
375
2555
TDA90
NOMESCO Finland
Removal wax from ear
3.5
11.3
51
147
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.6
11.2
330
2188
J01EA01
ATC
trimethoprim; systemic
1.4
11.2
792
6235
H91.8
ICD-10 Finland
Other specified hearing loss
4.1
11.2
42
103
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
11.2
807
6373
H02AB04
ATC
methylprednisolone; systemic
1.5
11.0
443
3148
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.8
11.0
176
978
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
10.9
396
2753
SPAT1216
SPAT
Assessment of functional ability
1.4
10.9
473
3418
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.1
10.8
123
602
SPAT1310
SPAT
Counselling related to known health issue
1.3
10.7
918
7429
UKC02
NOMESCO Finland
Cystoscopy
1.4
10.7
457
3287
SPAT1260
SPAT
Consultation of another employee
1.4
10.7
519
3827
R05
ICD-10 Finland
Cough
1.4
10.6
555
4145
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.9
10.5
151
811
R03DC03
ATC
montelukast; oral
1.4
10.5
447
3214
P01AB01
ATC
metronidazole; oral, rectal
1.3
10.5
1168
9797
H61.2
ICD-10 Finland
Impacted cerumen
1.8
10.4
171
960
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.7
10.4
230
1415
A04AA01
ATC
ondansetron; systemic, rectal
1.7
10.4
203
1204
3870A
ICD-9 Finland
Otosclerosis involving oval window, nonobliterative
+∞
10.4
10
*
M01AG02
ATC
tolfenamic acid; oral, rectal
1.5
10.4
433
3101
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
10.3
305
2022
SPAT1312
SPAT
General health counselling
1.3
10.3
905
7345
D82
ICPC
Teeth/gum disease
1.3
10.3
905
7346
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.8
10.3
177
1009
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.6
10.2
278
1809
R05
ICPC
Cough
1.4
10.1
620
4762
H01
ICPC
Ear pain/earache
1.6
10.1
266
1719
P06
ICPC
Sleep disturbance
1.6
10.0
247
1564
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
10.0
344
2360
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
10.0
1139
9570
RK520
NOMESCO Finland
NA
6.1
10.0
26
43
N06AB04
ATC
citalopram; systemic
1.4
9.9
624
4808
C03AA03
ATC
hydrochlorothiazide; oral
1.5
9.9
316
2136
R06AX27
ATC
desloratadine; oral
1.3
9.8
696
5462
N05BB51
ATC
hydroxyzine, combinations; systemic
8.7
9.8
20
23
S18
ICPC
Laceration/cut
1.3
9.7
1258
10729
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
9.7
2781
26195
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.4
9.7
650
5060
WZA90
NOMESCO Finland
Other doctors statement
1.4
9.6
611
4710
G04CA02
ATC
tamsulosin; oral
1.4
9.6
542
4097
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.6
9.6
255
1651
SPAT1104
SPAT
Monitoring of emergency patient
1.7
9.5
195
1175
R03AC03
ATC
terbutaline; inhalant
1.4
9.5
398
2849
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.9
9.5
138
746
-1
NOMESCO Finland
NA
1.3
9.4
861
7013
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.7
9.4
60
221
H80.8
ICD-10 Finland
Other otosclerosis
+∞
9.4
9
*
H28
ICPC
Limited function/disability (H)
3.8
9.4
38
101
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.7
9.3
193
1168
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.6
9.2
212
1321
L13
ICPC
Hip symptom/complaint
1.4
9.2
477
3555
WX290
NOMESCO Finland
Other blockade of nerve
1.3
9.1
1073
9025
J45.9
ICD-10 Finland
Asthma, unspecified
1.4
9.1
510
3849
XF402
NOMESCO Finland
ECG with work load test
1.5
9.1
328
2278
I49.4
ICD-10 Finland
Other and unspecified premature depolarization
2.1
9.0
105
520
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
9.0
1127
9552
M79.1
ICD-10 Finland
Myalgia
1.5
9.0
348
2453
R21
ICPC
Throat symptom/complaint
1.4
9.0
450
3333
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.5
8.9
318
2200
L02
ICPC
Back symptom/complaint
1.6
8.9
231
1487
R50.9
ICD-10 Finland
Fever, unspecified
1.5
8.9
365
2602
SPAT1325
SPAT
Vaccination
1.3
8.9
1037
8710
H81
ICPC
Excessive ear wax
1.4
8.9
467
3488
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
8.8
1317
11398
N06AX21
ATC
duloxetine; oral
1.5
8.8
292
1994
R12
ICD-10 Finland
Heartburn
1.6
8.6
199
1240
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
1.5
8.6
313
2177
H60.3
ICD-10 Finland
Other infective otitis externa
2.5
8.6
66
271
XQ800
NOMESCO Finland
Prick test
1.7
8.6
192
1189
34609
ICD-8 Finland
Migraine, Unspecified
4.2
8.6
31
75
TPH04
NOMESCO Finland
Cathetrisation of vein
1.3
8.5
575
4474
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.5
8.5
256
1710
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
8.4
415
3060
K04.0
ICD-10 Finland
Pulpitis
1.6
8.4
208
1323
H53.2
ICD-10 Finland
Diplopia
2.2
8.4
84
391
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
8.4
757
6143
J01CA08
ATC
pivmecillinam; oral
1.2
8.4
1222
10529
M54.2
ICD-10 Finland
Cervicalgia
1.7
8.4
182
1120
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.7
8.3
161
955
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.5
8.2
287
1979
M48.0
ICD-10 Finland
Spinal stenosis
1.4
8.2
363
2626
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.3
8.2
591
4639
A03FA02
ATC
cisapride; oral, rectal
1.6
8.2
235
1552
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
8.2
1190
10244
R03BA02
ATC
budesonide; inhalant
1.4
8.2
472
3581
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.5
8.1
267
1815
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
8.1
493
3769
H66.9
ICD-10 Finland
Otitis media, unspecified
1.9
8.1
121
663
SPAT1041
SPAT
Comprehensive hearing test
2.8
8.1
49
177
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
8.0
503
3863
M01AH01
ATC
celecoxib; oral (coxibs)
1.3
8.0
539
4187
SPAT1352
SPAT
Inspection, maintenance and instruction for use of hearing aid
2.8
8.0
48
172
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.6
8.0
210
1358
L86
ICPC
Back syndrome with radiating pain
1.7
7.9
156
931
C01CA24
ATC
epinephrine; parenteral
1.7
7.9
147
861
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
7.9
857
7114
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.7
7.9
147
866
DC1AI
NOMESCO Finland
Cone beam CT of ear
13.0
7.9
13
10
R4135
NOMESCO Finland
Rehabilitation for hearing problems
2.5
7.9
61
251
K07.60
ICD-10 Finland
Snapping jaw
1.8
7.9
119
654
R51
ICD-10 Finland
Headache
1.8
7.8
128
720
H03AA01
ATC
levothyroxine sodium; systemic
1.3
7.8
721
5864
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
7.7
436
3290
R06AX22
ATC
ebastine; oral
1.4
7.7
451
3429
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.3
7.7
694
5624
RK420
NOMESCO Finland
NA
8.0
7.6
16
20
M01AH02
ATC
rofecoxib; oral
1.4
7.6
400
2987
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
1.8
7.6
113
621
M01AC06
ATC
meloxicam; systemic, rectal
1.2
7.5
1079
9245
P01
ICPC
Feeling anxious/nervous/tense
1.6
7.5
186
1186
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.3
7.5
598
4762
H93.2
ICD-10 Finland
Other abnormal auditory perceptions
3.7
7.4
30
81
H83.8
ICD-10 Finland
Other specified diseases of inner ear
80.2
7.4
8
*
4133
FHL
Stapedectomy sampling
80.2
7.4
8
*
A03
ICPC
Fever
1.4
7.4
352
2580
R35
ICD-10 Finland
Polyuria
1.7
7.4
162
999
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.3
7.3
599
4783
N06AX16
ATC
venlafaxine; oral
1.4
7.3
336
2447
TAB00
NOMESCO Finland
Lumbar puncture
1.8
7.3
109
598
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.0
7.3
90
459
38699
ICD-8 Finland
NA
+∞
7.3
7
*
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
1.8
7.3
118
666
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.7
7.3
143
857
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.3
7.3
642
5182
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
3.5
7.2
31
88
C10AA05
ATC
atorvastatin; oral
1.2
7.2
1141
9877
M54.3
ICD-10 Finland
Sciatica
1.6
7.1
163
1015
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.4
7.1
312
2254
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.4
7.1
361
2674
Z45.3
ICD-10 Finland
Adjustment and management of implanted hearing device
12.0
7.1
12
10
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.3
7.0
564
4492
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.2
7.0
1033
8872
M77.1
ICD-10 Finland
Lateral epicondylitis
1.6
7.0
163
1023
N03AX11
ATC
topiramate; oral
2.3
7.0
62
277
J31.0
ICD-10 Finland
Chronic rhinitis
1.6
6.9
191
1251
SDA02
NOMESCO Finland
Parodonthologic therapy
1.3
6.9
864
7274
K04.1
ICD-10 Finland
Necrosis of pulp
1.5
6.9
248
1719
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.7
6.9
141
852
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.4
6.9
287
2051
UDM02
NOMESCO Finland
Sinoscopy
2.2
6.9
62
279
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.3
6.9
431
3310
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
2.1
6.9
69
325
SPAT1229
SPAT
Assessment of need for aid
1.5
6.9
236
1625
N06AB10
ATC
escitalopram; oral
1.3
6.9
474
3694
D33.30
ICD-10 Finland
Acoustic neuroma
3.7
6.8
28
77
C05AA08
ATC
fluocortolone; rectal, topical
1.4
6.8
397
3009
M01AC01
ATC
piroxicam; systemic, rectal
1.4
6.8
386
2921
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.2
6.7
1041
8974
G04BD12
ATC
mirabegron; oral
1.4
6.7
300
2175
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
1.6
6.7
172
1107
N05CF01
ATC
zopiclone; oral
1.2
6.7
949
8100
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.4
6.7
356
2663
C03BA04
ATC
chlortalidone; oral
22.5
6.7
9
*
C10AA07
ATC
rosuvastatin; oral
1.3
6.6
695
5727
ZXC10
NOMESCO Finland
Use of laser
2.3
6.6
57
251
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
6.6
648
5296
RK120
NOMESCO Finland
NA
5.5
6.6
18
33
A03CA02
ATC
clidinium and psycholeptics; oral
1.6
6.6
184
1207
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
3.5
6.6
28
80
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.6
6.6
143
884
C10AA01
ATC
simvastatin; oral
1.2
6.6
1332
11803
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.4
6.5
256
1811
N06AB06
ATC
sertraline; oral
1.4
6.5
256
1813
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.5
6.5
227
1570
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
1.8
6.5
98
543
A04
ICPC
Weakness/tiredness general
1.4
6.4
333
2480
H03
ICPC
Tinnitus, ringing/buzzing ear
2.3
6.4
56
249
M01AB08
ATC
etodolac; oral
1.5
6.4
206
1397
XA402
NOMESCO Finland
ENMG
2.0
6.4
73
365
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
2.0
6.4
77
393
M02AA10
ATC
ketoprofen; topical
1.3
6.4
451
3527
M79.0
ICD-10 Finland
Rheumatism, unspecified
1.7
6.4
112
652
R00.2
ICD-10 Finland
Palpitations
1.6
6.3
175
1147
D07AC01
ATC
betamethasone; topical
1.2
6.3
942
8080
H83.3
ICD-10 Finland
Noise effects on inner ear
5.5
6.3
17
31
R83
ICPC
Respiratory infection other
1.3
6.3
507
4041
M02AA07
ATC
piroxicam; topical
1.2
6.2
1094
9536
DFD20
NOMESCO Finland
Closure of rupture of round window
+∞
6.2
6
*
M79.7
ICD-10 Finland
Fibromyalgia
1.9
6.2
88
477
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
3.2
6.2
30
95
S06.0
ICD-10 Finland
Concussion
1.4
6.2
242
1713
J01MA06
ATC
norfloxacin; oral
1.3
6.2
392
3014
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.5
6.2
209
1434
H02AB07
ATC
prednisone; oral
1.3
6.2
397
3062
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.2
6.2
728
6083
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
1.8
6.1
97
545
N63
ICD-10 Finland
Unspecified lump in breast
1.6
6.1
156
1003
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.6
6.1
153
982
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.3
6.1
630
5179
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.5
6.1
214
1482
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.6
6.1
140
879
I49.1
ICD-10 Finland
Atrial premature depolarization
1.8
6.1
89
488
C07AB02
ATC
metoprolol; systemic
1.3
6.1
620
5087
DE2BM
NOMESCO Finland
Acoustic channel MRI examination with 3 Tesla magnet
12.5
6.1
10
8
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.3
6.1
561
4550
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.4
6.1
326
2440
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
1.7
6.1
116
692
R06.5
ICD-10 Finland
Mouth breathing
1.5
6.0
203
1391
R03BC03
ATC
nedocromil; inhalant
1.5
6.0
190
1286
EMB10
NOMESCO Finland
Tonsillectomy
1.8
6.0
96
541
H82
ICD-10 Finland
Vertiginous syndromes in diseases classified elsewhere
10.0
6.0
11
11
L16
ICPC
Ankle symptom/complaint
1.4
6.0
252
1807
N01
ICPC
Headache
1.5
6.0
204
1401
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
6.0
719
6014

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013707) Erythrocyte sedimentation rate by Westergren method
2806
23579
1.74
46.51
4.8
4.2
mm/h
11.8
13.3
6.51
2623
21682
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1374
9892
1.61
40.29
2.1
2.1
u/l
137.6
207.3
4.85
1275
9235
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1615
12398
1.53
34.03
4.1
3.8
ng/l
38.8
89.2
0.76
1104
8807
(3037467) Urinalysis macro (dipstick) panel - Urine
2577
21875
1.56
33.89
5.1
4.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1347
10089
1.52
31.03
2.4
2.5
u/l
56.1
57.6
0.36
1232
9281
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3387
31114
1.87
29.38
16.7
15.1
mg/l
21.8
24.3
4.04
2781
24840
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2827
24863
1.55
28.41
7.6
7.6
u/l
76.6
79.4
3.16
2636
23336
(3013826) Glucose [Moles/volume] in Serum or Plasma
2247
18903
1.47
27.70
4.3
4.6
mmol/l
6.7
6.8
1.33
2136
17722
(3031040) Bacteria [#/volume] in Urine by Automated count
2470
21219
1.48
26.94
5.1
4.8
e6/l
500.3
2400.9
2.54
44
299
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3176
28845
1.64
26.26
5.7
5.0
mu/l
1.9
2.1
1.00
2917
26221
(3019550) Sodium [Moles/volume] in Serum or Plasma
3477
32437
1.92
25.45
18.9
17.5
mmol/l
139.6
139.7
0.43
3411
31617
(3023103) Potassium [Moles/volume] in Serum or Plasma
3479
32526
1.89
24.34
19.1
17.6
mmol/l
3.9
4.0
7.00
3408
31658
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3182
29059
1.61
24.03
6.2
6.0
mmol/mol
39.7
40.1
1.86
2904
26688
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2745
24324
1.47
23.57
4.7
4.2
pmol/l
15.0
14.9
2.00
2485
21973
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2016
16950
1.41
22.75
5.4
6.2
umol/l
11.2
11.4
0.52
1903
16076
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1825
15100
1.40
22.52
5.0
5.9
mmol/l
1.2
1.2
3.42
1639
13612
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1972
16667
1.38
20.72
5.9
6.7
mmol/l
1.2
1.2
3.62
1664
14003
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
348
2059
1.76
20.26
2.5
2.4
au/ml
45.9
24.5
0.72
12
93
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3500
33041
1.82
20.04
11.8
10.8
u/l
24.9
25.2
0.43
3378
31772
(3013512) EKG study
1225
9601
1.41
20.04
4.2
4.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1612
13270
1.37
19.47
9.0
9.6
inr
1.2
1.3
1.04
433
3747
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3284
30535
1.58
19.40
5.2
4.8
mmol/l
5.9
6.0
0.93
2996
27629
(3020564) Creatinine [Moles/volume] in Serum or Plasma
3494
33014
1.79
19.29
19.4
17.8
umol/l
77.2
77.0
0.10
3494
33000
(40761511) CBC panel - Blood by Automated count
3415
32141
1.66
18.16
16.5
14.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3344
31336
1.59
17.82
5.6
5.1
mmol/l
2.7
2.7
0.07
3062
28592
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3281
30647
1.54
17.36
5.0
4.5
mmol/l
4.6
4.7
0.80
3010
28116
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
311
1862
1.73
17.32
1.3
1.3
au/ml
68.2
45.2
0.44
11
87
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2243
19640
1.35
17.32
3.2
3.1
u/l
49.3
50.1
0.18
2075
18091
(3048689) Calprotectin [Mass/mass] in Stool
517
3515
1.55
17.27
2.2
2.1
ug/g
108.9
134.6
1.32
414
2717
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3259
30407
1.53
17.24
4.9
4.5
mmol/l
1.5
1.5
2.11
2970
27717
(3007461) Platelets [#/volume] in Blood
3577
34181
1.89
17.02
24.7
22.4
e9/l
251.2
251.5
0.11
3507
33254
(3024731) MCV [Entitic volume]
3577
34189
1.89
16.89
24.6
22.3
fl
91.1
91.3
3.25
3532
33634
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
576
4027
1.51
16.87
4.9
4.6
%
33.0
33.1
0.07
410
2666
(3035941) MCH [Entitic mass]
3577
34190
1.89
16.87
24.6
22.3
pg
30.3
30.3
0.05
3532
33633
(3000963) Hemoglobin [Mass/volume] in Blood
3578
34203
1.89
16.86
24.9
22.5
g/l
134.7
133.5
6.04
3533
33654
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1227
9834
1.37
16.85
3.1
3.0
ng/l
1293.5
1519.5
0.62
1046
8454
(3026361) Erythrocytes [#/volume] in Blood
3577
34193
1.89
16.82
24.7
22.4
e12/l
4.5
4.4
4.71
3495
33146
(3010813) Leukocytes [#/volume] in Blood
3577
34197
1.89
16.75
24.8
22.4
e9/l
6.7
6.7
0.08
3495
33143
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3161
29355
1.47
16.64
4.4
4.0
mmol/l
1.3
1.3
0.58
2851
26528
(3035350) Ketones [Presence] in Urine by Test strip
1811
15443
1.33
16.29
4.1
3.9
estimate
0.0
0.0
0.00
306
2841
(3013115) Eosinophils [#/volume] in Blood
1894
16259
1.33
16.25
6.0
6.0
e9/l
0.2
0.2
0.12
1666
14169
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
856
6501
1.41
16.15
1.3
1.2
u/ml
1.3
1.6
0.52
208
1694
(3018677) aPTT in Platelet poor plasma by Coagulation assay
673
4909
1.45
15.84
1.9
2.1
s
29.2
29.9
2.66
646
4763
(3001604) Monocytes [#/volume] in Blood
1826
15636
1.33
15.74
5.8
5.7
e9/l
0.6
0.6
0.68
1589
13400
(3006315) Basophils [#/volume] in Blood
1832
15704
1.32
15.63
5.9
5.8
e9/l
0.0
0.0
0.02
1592
13467
(42870588) Differential panel, method unspecified - Blood
1318
10786
1.34
15.46
6.0
5.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1808
15486
1.32
15.44
5.5
5.2
estimate
0.0
0.0
0.80
315
2870
(3019198) Lymphocytes [#/volume] in Blood
1862
16037
1.32
15.18
5.9
5.8
e9/l
1.9
1.9
0.32
1649
14016
(40768797) Stomach Pathology biopsy report
616
4456
1.46
15.08
1.2
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
888
6862
1.38
14.96
1.9
1.8
mg/l
1.1
1.3
0.56
673
5286
(3037522) Nuclear Ab [Titer] in Serum
573
4094
1.47
14.95
1.4
1.3
titre
626.9
528.4
0.55
137
909
(3009261) Glucose [Presence] in Urine by Test strip
1820
15671
1.31
14.67
4.2
3.9
estimate
0.0
0.0
0.63
314
2824
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
717
5365
1.42
14.55
1.3
1.3
iu/ml
28.8
34.1
0.75
208
1678
(36660697) Celiac disease serology panel - Serum
358
2350
1.58
13.85
1.1
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
681
5107
1.41
13.55
1.3
1.2
u/ml
10.4
12.3
0.31
248
1907
(3026493) Urate [Moles/volume] in Serum or Plasma
1035
8310
1.34
13.40
2.6
2.7
umol/l
3968.3
5546.0
0.66
892
7123
(3019069) Monocytes/100 leukocytes in Blood
1711
14753
1.29
13.07
6.7
6.3
%
8.5
8.7
1.75
1595
13735
(3006504) Eosinophils/100 leukocytes in Blood
1703
14676
1.29
13.06
6.3
6.0
%
2.8
2.8
0.12
1585
13602
(3013650) Neutrophils [#/volume] in Blood by Automated count
2073
18341
1.29
12.87
8.4
9.1
e9/l
4.1
4.1
0.01
1815
15978
(3002030) Lymphocytes/100 leukocytes in Blood
1742
15085
1.29
12.75
6.5
6.1
%
28.1
27.5
1.57
1608
13968
(3018010) Neutrophils/100 leukocytes in Blood
1718
14858
1.29
12.68
6.1
5.9
%
57.0
57.6
1.19
1597
13814
(3024561) Albumin [Mass/volume] in Serum or Plasma
1665
14347
1.29
12.63
4.2
4.7
g/l
35.8
35.2
5.30
1530
13291
(3019225) pH of Specimen
472
3356
1.46
12.50
4.1
4.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
733
5654
1.37
12.18
1.5
1.5
g/l
2.3
2.5
1.33
414
3338
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
809
6337
1.35
12.17
4.1
3.8
ng/l
218.7
386.0
1.27
636
5098
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1593
13714
1.28
11.94
2.1
2.0
pmol/l
98.7
95.2
1.84
789
6885
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1978
17532
1.27
11.51
2.9
2.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
1642
14280
1.27
11.02
6.4
6.0
%
0.7
0.7
0.98
1527
13240
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1387
11833
1.27
10.88
4.5
4.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3122
29454
1.35
10.54
15.0
14.2
ml/min/173m2
77.7
77.7
0.04
2635
24414
(40768804) Tissue Pathology biopsy report
1525
13220
1.26
10.29
2.2
2.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1515
13138
1.26
10.14
2.9
2.8
ug/l
123.9
129.0
0.23
1384
12071
(3036481) Cortisol [Moles/volume] in Serum or Plasma
402
2892
1.44
9.94
2.1
2.2
nmol/l
373.7
374.3
0.02
367
2638
(4010399)
323
2256
1.47
9.32
1.4
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
307
2129
1.48
9.19
2.6
3.2
e9/l
3.8
4.1
1.91
227
1627
(3019150) Specific gravity of Urine by Refractometry
833
6786
1.29
9.16
4.7
4.4
kg/l
1.0
1.0
1.80
146
1037
(3015377) Calcium [Moles/volume] in Serum or Plasma
1327
11458
1.24
8.90
2.9
3.4
mmol/l
2.4
2.4
0.05
1107
9934
(3026008) Bacteria identified in Urine by Culture
1224
10498
1.25
8.67
3.4
3.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
566
4403
1.34
8.66
27.2
25.9
inr
1.4
1.4
0.41
95
605
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
147
876
1.71
8.42
1.3
1.2
u/ml
15.2
43.8
1.24
12
56
(3030981) Hyaline casts [#/volume] in Urine by Automated count
241
1625
1.52
8.28
2.5
2.7
e6/l
0.1
0.3
3.46
232
1581
(3004616) Nuclear Ab [Presence] in Serum
81
403
2.03
8.19
1.3
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1541
13609
1.22
8.15
2.4
2.2
nmol/l
80.1
79.3
0.52
1382
12112
(3005322) IgE [Units/volume] in Serum or Plasma
260
1792
1.48
8.04
1.3
1.3
u/ml
250.0
195.6
0.28
247
1634
(3005719) IgG [Mass/volume] in Serum or Plasma
321
2309
1.43
7.94
3.0
2.8
g/l
10.0
10.5
1.52
295
2102
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
984
8330
1.25
7.66
2.4
2.2
mg/l
2.9
3.0
0.67
854
7063
(3022145) Colonoscopy Study observation
460
3539
1.34
7.55
1.3
1.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
116
669
1.76
7.50
1.2
1.2
u/ml
3.2
3.4
—
7
54
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
81
420
1.95
7.34
2.6
2.2
mg/l
25.2
23.6
0.09
27
103
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
471
3653
1.33
7.31
2.4
2.6
umol/l
9.4
8.4
0.31
414
3161
(3041096) Erythrocytes [Presence] in Urine by Automated
960
8153
1.24
7.19
3.9
3.6
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
11
16
6.89
7.15
1.8
1.4
pmol/l
15.8
37.5
0.47
11
11
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
128
773
1.68
7.04
1.1
1.1
u/ml
5.6
6.8
—
5
83
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
132
808
1.66
6.90
1.3
1.2
u/ml
2.2
6.1
0.58
12
92
(3015171) Extractable nuclear Ab [Units/volume] in Serum
182
1207
1.53
6.80
1.3
1.2
u/ml
1.3
1.5
0.08
22
110
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
133
820
1.64
6.77
1.3
1.3
u/ml
6.9
7.6
0.05
19
145
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
151
961
1.60
6.76
1.7
1.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
1290
11351
1.21
6.71
3.7
3.7
e6/l
84.6
118.8
1.04
931
8071
(3009343) pH of Capillary blood
271
1960
1.41
6.52
3.2
3.7
ph
7.4
7.4
0.81
41
259
(3019309) Folate [Moles/volume] in Red Blood Cells
778
6520
1.24
6.50
1.7
1.8
nmol/l
1116.8
1177.4
1.12
601
4899
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
545
4383
1.28
6.45
1.5
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
962
8262
1.22
6.35
5.5
5.2
ug/l
3.9
3.6
0.09
872
7342
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
45
197
2.30
6.35
1.0
1.1
mg/l
271.6
281.3
0.13
40
167
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
44
191
2.32
6.33
1.1
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
2412
22531
1.20
6.29
4.2
3.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
292
2156
1.38
6.24
1.2
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
1149
10056
1.21
6.23
3.5
4.1
ph
7.4
7.4
0.66
190
1904
(3003327) Ova and parasites identified in Stool by Light microscopy
142
911
1.58
6.17
1.7
1.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
271
1986
1.39
6.06
3.2
3.7
kpa
5.1
5.2
0.60
249
1835
(3029937) Albumin [Presence] in Urine by Test strip
970
8379
1.21
5.99
4.8
4.3
estimate
0.0
0.0
0.26
309
2784
(3002582) Erythrocytes [#/volume] in Urine
1111
9735
1.20
5.88
3.2
3.2
e6/l
63.5
80.8
0.46
857
7479
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
45
204
2.22
5.87
1.1
1.1
mg/l
35.3
41.5
0.57
40
170
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
258
1886
1.39
5.86
3.2
3.6
mmol/l
1.6
2.0
0.89
188
1418
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
207
1459
1.44
5.77
1.0
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
247
1804
1.40
5.65
2.5
2.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
175
1200
1.48
5.63
3.7
3.9
mmol/l
25.0
24.9
0.12
161
1100
(3020630) Protein [Mass/volume] in Serum or Plasma
362
2819
1.31
5.46
2.7
2.7
g/l
66.2
66.4
0.23
332
2568
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
43
198
2.19
5.43
1.8
1.7
nmol/l
17.2
17.0
0.07
43
182
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
76
430
1.78
5.35
1.3
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1141
10095
1.19
5.32
3.1
3.2
u/l
30.1
36.8
2.87
1068
9551
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
39
174
2.25
5.32
1.2
1.5
u/l
5.1
7.3
1.23
33
152
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
81
470
1.74
5.24
1.3
1.3
nmol/l
0.2
0.4
—
5
31
(3012516) Albumin [Mass/volume] in Urine
1094
9655
1.19
5.24
3.2
3.2
mg/l
506.0
356.6
0.38
633
5999
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
397
3151
1.29
5.20
1.6
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
66
363
1.83
5.11
4.0
4.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
199
1426
1.42
5.11
1.3
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
57
299
1.92
5.10
1.0
1.1
—
5.4
—
0
5
(3020682) Albumin/Creatinine [Ratio] in Urine
1146
10175
1.18
5.08
4.0
3.9
mg/mmol
7.2
8.7
0.53
645
6294
(3047181) Lactate [Moles/volume] in Blood
150
1022
1.49
5.02
4.9
6.9
mmol/l
1.4
1.3
0.17
133
902
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
71
402
1.78
5.01
1.4
1.3
nmol/l
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
134
893
1.52
4.99
2.1
1.6
g/l
0.2
0.2
0.24
129
848
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
772
6630
1.21
4.96
4.9
4.4
%
22.0
21.8
0.15
375
3337
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
645
5443
1.22
4.95
1.9
1.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
51
261
1.97
4.92
1.0
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
895
7799
1.19
4.90
1.5
1.6
nmol/l
20.6
20.7
0.07
758
6635
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
136
921
1.49
4.71
2.0
1.6
g/l
1.2
1.2
0.14
131
877
(3009508) Creatinine [Moles/volume] in Urine
1120
9981
1.17
4.68
3.2
3.1
mmol/l
7.1
7.1
0.12
931
8346
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
335
2638
1.30
4.68
2.9
3.6
ng/l
76.7
90.4
3.06
283
2249
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
370
2955
1.28
4.63
3.2
3.0
ng/l
212.1
211.0
0.01
347
2700
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
51
268
1.92
4.58
1.3
1.2
u/ml
112.0
67.5
—
5
11
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1634
15014
1.16
4.54
4.0
4.0
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
52
277
1.89
4.49
1.3
1.2
—
50.0
—
0
13
(3022313) Gas panel - Capillary blood
193
1409
1.39
4.49
3.4
3.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
301
2351
1.30
4.47
2.6
2.5
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
51
271
1.89
4.44
1.3
1.2
u/ml
24.5
55.3
—
6
25
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
255
1949
1.33
4.43
3.3
3.3
pmol/l
4.4
4.4
0.30
226
1712
(3009542) Hematocrit [Volume Fraction] of Blood
2876
27582
1.18
4.42
17.3
16.4
%
39.1
39.1
0.00
1882
18790
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
497
4141
1.23
4.30
8.0
7.4
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
35
164
2.14
4.30
1.2
1.5
ug/l
5.9
8.9
1.60
30
141
(3000850) Epithelial cells [#/volume] in Urine
785
6838
1.19
4.26
2.5
2.6
e6/l
4.4
5.9
4.29
674
5989
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
63
364
1.74
4.21
1.5
1.4
u/l
31.8
32.4
0.04
50
303
(3045424) Erythrocytes [Presence] in Urine
87
548
1.60
4.20
1.5
1.6
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
149
1054
1.43
4.17
1.6
1.6
titre
80.0
284.6
—
7
52
(3019060) Gas panel - Arterial blood
283
2222
1.30
4.07
4.2
4.9
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
65
384
1.70
4.03
1.3
1.3
u/ml
88.7
53.6
—
8
24
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
96
628
1.54
3.97
1.3
1.2
u/ml
52.6
43.9
0.13
11
70
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
36
178
2.03
3.88
1.1
1.1
nmol/l
0.3
6.6
—
7
39
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
99
0.00
3.84
0.0
2.3
—
149.4
—
0
85
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
155
1123
1.40
3.82
1.6
1.6
—
—
—
0
0
(3000492) Spirometry study
342
2775
1.26
3.78
1.5
1.5
—
—
—
0
0
(4027681)
33
160
2.07
3.76
1.2
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
1003
8996
1.16
3.72
3.1
3.1
e6/l
0.4
0.5
0.73
759
6821
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
175
1300
1.36
3.71
1.7
1.8
u/l
38.7
39.1
0.11
159
1148
(40761535) Cells panel - Urine sediment
340
2768
1.25
3.66
4.0
3.7
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
620
5361
1.19
3.64
3.0
3.2
mmol/l
0.8
0.8
0.93
557
4984
(3049717) Cytology report of Urine Cyto stain
164
1210
1.37
3.64
2.6
2.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
136
974
1.41
3.60
1.4
1.4
ug/g
286.9
276.4
0.22
83
557
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
171
1278
1.35
3.51
2.0
1.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
882
7869
1.16
3.49
2.3
2.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
84
551
1.54
3.47
2.0
1.8
u/l
5578.1
3747.3
0.16
25
211
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
184
1393
1.34
3.47
2.2
1.9
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
57
340
1.69
3.46
2.3
2.0
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
592
5128
1.18
3.40
2.3
2.5
umol/l
13.4
12.7
1.26
546
4741
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
181
1372
1.34
3.39
4.7
5.6
%
1.6
1.6
0.18
169
1283
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
442
3730
1.21
3.39
3.7
4.2
u/l
242.1
248.6
0.40
411
3517
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
352
2903
1.23
3.38
2.5
2.4
ug/l
6.9
6.7
0.04
300
2535
(3024980) IgG subclass 4 [Mass/volume] in Serum
73
470
1.56
3.29
1.8
1.6
g/l
0.7
0.8
0.62
54
350
(3002179) Metamyelocytes/100 leukocytes in Blood
303
2466
1.25
3.29
3.4
3.9
%
0.4
0.6
0.81
67
556
(3000494) Fungus identified in Specimen by Culture
436
3690
1.21
3.25
1.5
1.4
—
—
—
0
0
(4024509)
58
356
1.64
3.19
1.7
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
313
2570
1.24
3.15
3.7
4.1
%
0.1
0.2
0.45
83
719
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
811
7251
1.15
3.09
1.6
1.7
pmol/l
550.4
30810886.1
5.44
672
5972
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
93
642
1.46
3.05
1.2
1.4
e6/l
12.5
29.8
0.94
81
489
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
16
62
2.59
3.04
1.1
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
835
7490
1.15
3.03
4.1
3.9
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
84
569
1.49
3.03
1.5
1.3
u/l
11.9
12.8
0.26
72
455
(3044640) Blood type and Crossmatch panel - Blood
1126
10304
1.13
3.02
2.4
2.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
93
644
1.46
3.01
1.3
1.4
e6/l
1002.1
1505.0
0.24
82
521
(3028026) IgM [Mass/volume] in Serum or Plasma
230
1833
1.27
3.01
2.0
1.9
g/l
1.1
1.4
2.07
206
1665
(3017181) Myelocytes/100 leukocytes in Blood
326
2703
1.23
3.00
3.7
4.1
%
0.7
0.9
0.71
88
779
(3018572) Chloride [Moles/volume] in Blood
104
736
1.42
3.00
6.0
7.9
mmol/l
105.1
105.0
0.07
95
658
(3039000) Anion gap in Blood
104
736
1.42
3.00
6.0
7.9
mmol/l
11.1
11.1
0.09
95
658
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
147
1103
1.35
2.99
2.6
2.7
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
66
426
1.56
2.98
1.3
1.4
mu/l
71.0
44.6
0.80
60
378
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
175
1352
1.31
2.92
1.9
2.0
ug/l
2.4
2.4
0.00
144
1193
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
245
1977
1.26
2.90
1.2
1.2
iu/ml
106.7
155.1
1.47
102
721
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
295
2431
1.23
2.89
1.6
1.6
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
17
70
2.44
2.87
1.9
2.0
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
171
1322
1.31
2.84
1.1
1.1
titre
52.0
174.7
—
5
35
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
19
83
2.30
2.83
1.1
1.1
%
98.4
85.5
—
10
44
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
18
77
2.34
2.81
1.1
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
259
2112
1.24
2.80
6.1
7.0
mmol/l
24.9
24.6
0.53
240
1963
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
31
165
1.89
2.80
1.9
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
31
165
1.89
2.80
1.9
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
31
165
1.89
2.80
1.9
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
31
165
1.89
2.80
1.9
1.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
40
231
1.74
2.79
2.2
1.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
102
730
1.41
2.79
2.2
2.3
g/l
138.5
127.2
4.47
72
531
(36304419) Bacteria [Presence] in Urine
960
8738
1.13
2.77
3.1
3.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
175
1365
1.30
2.74
4.8
5.6
%
0.9
0.9
1.13
164
1278
(3007853) Bacteria identified in Skin by Aerobe culture
430
3697
1.18
2.71
1.7
1.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
264
2168
1.23
2.69
3.5
3.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
747
6705
1.14
2.67
4.8
4.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
50
311
1.62
2.67
2.1
2.8
—
—
—
0
0
(4094501)
114
839
1.37
2.66
1.1
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
34
190
1.80
2.66
1.4
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
488
4249
1.17
2.65
4.0
5.6
mmol/l
1.0
1.0
2.20
448
3923
(3026782) Osmolality of Urine
715
6408
1.14
2.61
2.8
2.8
mosm/kgh2o
522.5
537.6
1.02
592
5458
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
34
192
1.78
2.58
1.4
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
63
419
1.51
2.54
1.6
1.4
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
18
81
2.23
2.53
1.2
1.1
pmol/l
221.9
320.0
1.06
13
62
(3025941) Bacteria identified in Stool by Culture
212
1712
1.25
2.53
1.3
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
83
587
1.42
2.46
1.1
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
930
8507
1.12
2.45
1.8
1.6
mmol/l
1.4
1.4
0.09
779
7081
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
26
137
1.90
2.45
1.1
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
199
1602
1.26
2.45
2.2
2.2
nmol/l
11.8
12.2
0.28
178
1394
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
25
131
1.91
2.40
2.1
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
25
131
1.91
2.40
2.1
1.8
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
6
12
5.01
2.40
1.5
1.8
ng/l
213.7
220.4
—
6
12
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
618
5517
1.14
2.39
2.8
2.7
e6/l
1.2
1.2
0.17
390
3174
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
63
425
1.49
2.39
1.6
1.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
12
46
2.61
2.35
1.3
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
25
132
1.90
2.35
2.2
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
432
3764
1.17
2.34
1.7
1.8
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
142
1104
1.30
2.32
1.4
1.3
iu/l
30.2
33.8
0.67
120
946
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
108
809
1.34
2.30
1.9
2.0
mg/l
13.6
11.8
0.18
99
741
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
243
2021
1.22
2.24
1.7
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
979
9027
1.11
2.22
4.2
4.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
330
2827
1.18
2.21
2.5
2.5
e9/l
69.0
70.1
0.23
270
2120
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
35
210
1.67
2.19
1.3
1.3
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
16
74
2.17
2.14
1.0
1.1
umol/24h
0.9
0.7
—
6
38
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
59
403
1.47
2.14
1.2
1.3
pmol/l
289.0
277.6
0.13
47
320
(3011412) CD3 cells [#/volume] in Blood
43
274
1.58
2.14
2.4
2.1
e9/l
1.2
1.1
0.14
25
173
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
430
3777
1.16
2.11
1.7
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
65
454
1.44
2.11
1.4
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
230
1915
1.21
2.11
1.7
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
34
205
1.66
2.10
1.3
1.3
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
39
244
1.60
2.09
1.7
1.5
u/ml
24.1
17.8
0.39
12
50
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
705
6402
1.12
2.09
2.8
3.1
mmol/l
2.5
2.5
0.47
591
5598
(3027945) Reticulocytes/100 erythrocytes in Blood
427
3755
1.15
2.07
2.5
2.5
%
1.8
1.8
0.15
383
3318
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
17
82
2.08
2.06
1.0
1.3
%
107.9
81.4
—
9
44
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
99
747
1.33
2.04
1.3
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
60
416
1.45
2.03
1.6
1.4
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
94
705
1.34
2.02
2.1
3.0
kpa
8.4
7.9
2.07
87
653
(3018133) Calcium [Moles/volume] in Urine
9
32
2.82
2.00
1.6
1.6
mmol/l
2.7
3.1
—
9
25
(3048879) Bone marrow aspiration report
19
97
1.96
2.00
2.1
1.7
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
26
148
1.76
1.98
1.3
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
26
148
1.76
1.98
1.3
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
2641
25640
1.10
1.96
21.4
19.8
g/l
332.4
331.4
7.20
2628
25426
(3020618) Glucose [Moles/volume] in Synovial fluid
5
11
4.55
1.94
1.0
1.1
mmol/l
5.7
4.6
—
5
5
(3017704) Immunofixation for Urine
32
195
1.65
1.92
1.7
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
50
339
1.48
1.91
1.9
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
60
422
1.43
1.90
1.6
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
13
267
0.49
1.90
1.3
1.4
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
19
99
1.92
1.90
1.2
1.2
g/l
0.3
0.3
0.63
14
80
(3045414) Leukocytes [Presence] in Urine
180
1480
1.23
1.90
1.9
2.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
164
1336
1.24
1.88
1.7
2.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
59
415
1.43
1.88
1.6
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
59
415
1.43
1.88
1.6
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
164
1337
1.24
1.87
1.7
2.5
g/l
7.4
7.5
0.06
118
1000
(3037756) Immunofixation for Serum or Plasma
96
732
1.32
1.87
1.8
1.6
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
8
28
2.86
1.86
1.3
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
36
230
1.57
1.81
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
36
230
1.57
1.81
1.2
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
414
3670
1.14
1.81
3.4
4.0
ug/l
12.1
26.8
1.16
334
2989
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
163
1335
1.23
1.80
1.7
2.5
g/l
3.9
3.8
0.28
109
953
(3027273) Bicarbonate [Moles/volume] in Venous blood
196
1636
1.21
1.79
3.3
3.1
mmol/l
25.6
25.4
0.51
190
1584
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
36
231
1.56
1.78
1.2
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
13
260
0.50
1.77
1.3
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
524
4724
1.13
1.77
2.2
2.5
g/l
2.4
2.3
2.97
478
4362
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
29
177
1.64
1.76
1.1
1.0
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
14
67
2.09
1.75
1.1
1.1
u/ml
0.0
2.2
—
9
29
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
36
232
1.56
1.75
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
36
232
1.56
1.75
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
36
232
1.56
1.75
1.2
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
563
5101
1.12
1.75
3.0
2.9
e6/l
3.6
2.9
0.63
338
2778
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
15
74
2.03
1.74
2.7
2.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
13
258
0.50
1.74
1.3
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
113
892
1.28
1.72
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
29
178
1.63
1.72
1.1
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
71
526
1.36
1.70
1.4
1.4
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
35
226
1.55
1.70
1.0
1.0
ng/l
706.9
706.8
0.00
25
139
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
35
226
1.55
1.70
1.0
1.0
ng/l
303.9
323.7
0.18
27
142
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
12
55
2.19
1.67
1.2
1.4
ng/l
84.3
104.8
0.43
12
55
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
8
31
2.58
1.66
1.0
1.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
279
2421
1.16
1.65
3.7
4.1
%
0.6
0.4
0.12
71
613
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
152
1249
1.23
1.65
1.7
2.5
g/l
3.0
3.1
0.66
111
978
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
35
228
1.54
1.64
1.0
1.0
ng/l
44.9
45.4
0.02
26
140
(3017354) Segmented neutrophils/100 leukocytes in Blood
48
335
1.44
1.63
3.4
3.4
%
51.1
57.4
0.91
33
216
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
21
120
1.75
1.62
1.0
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
489
4416
1.12
1.61
2.3
2.6
%
22.4
22.4
0.01
391
3747
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
42
287
1.47
1.59
1.7
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
42
287
1.47
1.59
1.7
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
42
287
1.47
1.59
1.7
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
137
1122
1.23
1.55
3.2
3.0
g/l
0.3
0.3
0.06
48
430
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
27
168
1.61
1.55
1.0
1.0
u/l
1.0
1.1
0.83
13
93
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
122
988
1.24
1.53
1.3
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
93
729
1.28
1.53
1.2
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
116
1431
0.80
1.53
1.5
1.5
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
7
27
2.60
1.51
1.0
1.2
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
43
301
1.43
1.46
1.5
1.4
g/l
2.5
2.9
0.93
29
208
(3024139) IgG subclass 3 [Mass/volume] in Serum
43
301
1.43
1.46
1.5
1.4
g/l
0.4
0.4
0.10
31
209
(3027135) IgG subclass 1 [Mass/volume] in Serum
43
301
1.43
1.46
1.5
1.4
g/l
6.8
7.0
0.17
29
208
(3021901) Oxygen saturation in Capillary blood
78
602
1.30
1.46
2.2
2.9
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
38
260
1.47
1.45
1.2
1.5
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
31
203
1.53
1.45
1.5
1.3
titre
33.3
75.9
—
6
17
(3006922) Hepatitis E virus Ab [Presence] in Serum
29
187
1.56
1.45
1.1
1.1
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
5
16
3.13
1.44
2.2
1.6
umol/24h
347.8
341.8
—
5
16
(40767503) Oxygen content in Capillary blood by calculation
89
702
1.27
1.42
2.7
2.6
%
18.3
15.9
5.28
51
361
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
112
908
1.24
1.42
1.5
1.6
iu/ml
0.1
7.0
0.59
17
199
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
10
46
2.18
1.39
1.6
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
59
441
1.34
1.39
1.3
1.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
231
2008
1.16
1.38
3.0
3.0
g/l
128.3
127.6
0.23
224
1957
(3027801) Oxygen [Partial pressure] in Arterial blood
422
3819
1.12
1.37
4.7
7.0
kpa
12.4
12.2
0.22
396
3635
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
136
1132
1.21
1.35
1.7
2.6
g/l
0.8
1.1
0.52
115
980
(3036670) Protein [Mass/volume] in Synovial fluid
17
97
1.76
1.34
1.2
1.2
g/l
36.3
38.7
—
10
51
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
10
47
2.13
1.33
1.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
11
54
2.04
1.32
1.2
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
40
0.00
1.32
0.0
13.3
—
5.4
—
0
40
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
38
266
1.43
1.32
1.2
1.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
26
168
1.55
1.31
1.3
1.7
u/field
4.2
1.9
0.65
17
117
(3015235) Bicarbonate [Moles/volume] in Capillary blood
102
827
1.24
1.31
2.1
3.3
mmol/l
25.1
25.1
0.04
86
720
(3029075) Extractable nuclear Ab panel - Serum
15
83
1.81
1.31
1.1
1.0
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
421
3821
1.11
1.31
4.7
7.0
kpa
5.1
5.1
0.39
396
3639
(3032773) Endomysium IgG Ab [Titer] in Serum
34
234
1.46
1.29
1.1
1.1
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
8
34
2.36
1.29
2.0
2.7
—
33.4
—
0
5
(3003396) Base excess in Arterial blood by calculation
420
3815
1.11
1.29
4.7
7.0
mmol/l
1.3
1.2
0.25
323
2966
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
522
4797
1.10
1.28
3.1
3.1
ug/l
0.8
0.8
0.11
345
3288
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
44
2.05
1.26
1.0
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
21
130
1.62
1.26
1.3
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
24
154
1.56
1.25
1.2
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
48
354
1.36
1.25
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
98
796
1.24
1.25
1.8
1.8
iu/l
3.4
4.6
1.78
35
270
(4146454)
49
363
1.35
1.24
2.7
2.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
158
0.51
1.24
1.0
1.3
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
6
25
2.40
1.24
1.3
1.2
—
—
—
0
0
(44813793)
29
195
1.49
1.24
1.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
13
70
1.86
1.23
1.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
49
364
1.35
1.23
2.3
2.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
188
2165
0.86
1.22
1.8
1.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
44
322
1.37
1.21
2.0
1.6
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
27
180
1.50
1.20
1.1
1.1
u/l
95.9
82.7
0.48
21
131
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
27
180
1.50
1.20
1.1
1.1
u/l
26.0
26.4
0.02
20
127
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
6
26
2.31
1.18
1.2
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
9
171
0.53
1.17
1.7
2.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
34
0.00
1.16
0.0
1.3
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
8
39
2.05
1.15
1.0
1.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
5
20
2.50
1.15
1.4
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
12
210
0.57
1.14
1.0
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
36
0.00
1.14
0.0
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
71
563
1.27
1.13
1.2
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
55
422
1.31
1.13
2.7
2.4
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
18
111
1.62
1.12
1.2
1.1
ng/l
1610.4
436.7
—
5
28
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
146
1249
1.18
1.11
1.9
2.5
g/l
10.1
10.3
0.38
121
1058
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
46
345
1.34
1.11
1.2
1.3
mmol/l
7.8
7.6
0.13
33
249
(4062490)
41
302
1.36
1.10
1.5
1.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
30
209
1.44
1.10
1.2
1.8
umol/l
16.4
9.6
0.21
19
144
(3028433) Virus identified in Specimen by Culture
17
104
1.64
1.09
1.5
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
118
994
1.19
1.08
1.6
2.4
g/l
0.0
0.0
0.00
106
911
(3012501) Base excess in Blood by calculation
91
749
1.22
1.06
3.3
4.5
mmol/l
2.2
2.7
1.39
53
522
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
91
749
1.22
1.06
1.5
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
492
4555
1.09
1.06
1.8
2.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
530
4923
1.09
1.06
1.4
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
31
430
0.72
1.05
3.7
4.9
umol/l
361.6
355.9
0.08
24
373
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
12
67
1.79
1.04
1.5
1.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
99
824
1.21
1.04
1.2
1.2
titre
124.0
87.0
—
10
64
(3019768) Coxiella burnetii Ab [Presence] in Serum
5
22
2.27
1.03
1.0
1.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
23
154
1.50
1.03
1.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
23
154
1.50
1.03
1.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
22
146
1.51
1.03
4.4
4.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
78
636
1.23
1.01
1.2
1.3
mmol/l
65.0
61.2
0.38
59
514
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
38
283
1.35
0.98
1.2
1.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
129
1107
1.17
0.98
2.9
3.5
mg/l
45.0
63.9
0.48
108
907
(3034860) Kappa light chains.free [Mass/volume] in Serum
129
1107
1.17
0.98
2.9
3.5
mg/l
33.5
107.9
0.84
109
909
(3017569) Oxygen content in Arterial blood
9
160
0.56
0.98
1.8
2.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
110
933
1.18
0.96
1.5
1.7
—
—
—
0
0
(3020891) Body temperature
158
1381
1.15
0.95
4.4
4.3
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
40
302
1.33
0.95
4.0
5.0
u/ml
15.4
59.1
2.42
11
83
(3023420) DNA double strand Ab [Units/volume] in Serum
43
329
1.31
0.94
2.6
1.4
iu/ml
26.2
21.3
—
5
15
(3022493) Free Hemoglobin [Mass/volume] in Plasma
18
117
1.54
0.93
5.8
6.3
mg/l
70.8
62.7
—
9
85
(3020717) Zinc [Moles/volume] in Serum or Plasma
22
150
1.47
0.92
1.3
1.4
umol/l
17.5
23.0
0.49
22
141
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
171
1507
1.14
0.92
2.4
2.5
%
0.7
0.7
0.02
161
1438
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
287
2612
1.11
0.91
2.6
2.6
ml/min/173m2
68.3
63.5
1.38
110
1069
(3035637) Corticotropin [Mass/volume] in Plasma
49
384
1.28
0.90
1.4
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
328
3007
1.10
0.90
2.8
3.5
mmol/l
1.8
2.0
0.81
276
2440
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
11
63
1.75
0.90
1.2
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
28
202
1.39
0.89
2.9
3.7
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
12
71
1.69
0.88
1.1
1.3
mmol/l
2.5
1.6
—
6
47
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
23
160
1.44
0.88
2.1
2.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
772
8124
0.94
0.88
1.3
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
83
693
1.20
0.88
3.9
3.5
mg/l
28.9
27.6
0.10
52
431
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
127
0.55
0.88
2.0
1.4
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
13
79
1.65
0.88
1.8
1.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
110
943
1.17
0.87
1.2
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
46
360
1.28
0.87
1.2
1.2
u/l
53.8
59.5
0.41
30
253
(3029396) Erythrocyte agglutination [Presence] in Blood
6
30
2.00
0.87
3.0
3.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
87
732
1.19
0.86
3.0
3.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
78
650
1.20
0.85
1.6
1.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
66
541
1.22
0.85
4.0
3.6
%
1.3
1.5
0.25
50
423
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
65
532
1.23
0.85
1.2
1.2
u/l
35.7
35.3
0.01
58
457
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
26
187
1.39
0.85
2.9
2.2
e6/l
646.5
727.2
0.24
15
73
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
17
112
1.52
0.84
1.4
2.4
umol/l
180.7
144.6
—
7
61
(3020393) Adenovirus Ag [Presence] in Stool
6
31
1.94
0.84
1.2
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
39
300
1.30
0.84
1.2
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
120
1040
1.16
0.84
1.6
2.3
g/l
38.2
37.5
0.58
103
890
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
29
214
1.36
0.82
2.0
1.9
%
13.0
14.7
0.33
13
86
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
94
801
1.18
0.81
1.8
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1437
13922
1.05
0.81
10.2
9.8
e9/l
0.0
0.0
1.16
1209
11344
(42529406) Shigella sp [Presence] in Stool by Culture
110
950
1.16
0.81
1.2
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
13
81
1.61
0.81
1.5
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
160
1420
1.13
0.80
1.4
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
65
784
0.83
0.80
2.3
2.3
ug/min
81.9
98.6
0.15
43
470
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
329
3037
1.09
0.80
2.3
2.3
u/l
33.2
39.1
0.92
279
2589
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
19
271
0.70
0.80
1.3
1.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
328
3028
1.09
0.79
2.8
3.5
kpa
5.7
5.9
1.49
322
2934
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
45
564
0.80
0.79
1.3
1.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
28
207
1.36
0.79
5.0
6.6
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
6
33
1.82
0.79
8.8
4.4
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
16
235
0.68
0.78
1.8
1.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
332
3070
1.09
0.78
1.5
1.7
%
1.5
1.5
0.20
290
2666
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
12
187
0.64
0.78
1.4
1.5
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
40
313
1.28
0.77
1.1
1.1
—
2.9
—
0
5
(4281824)
31
406
0.76
0.77
1.1
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
28
208
1.35
0.77
1.3
1.3
u/ml
0.1
0.9
1.01
15
102
(1002224) Polysomnography panel
122
1068
1.15
0.76
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
223
2026
1.11
0.76
1.3
1.3
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
35
270
1.30
0.76
1.1
1.1
u/ml
7.3
2.5
0.35
13
104
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
71
595
1.20
0.75
1.9
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
44
350
1.26
0.75
1.6
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
37
288
1.29
0.75
1.1
1.2
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
14
91
1.54
0.75
1.4
1.3
%
36.3
33.4
—
8
60
(3002256) Pathology report gross observation
455
4270
1.07
0.75
1.3
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
24
175
1.37
0.74
2.3
1.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
51
414
1.24
0.74
1.2
1.1
u/ml
2.5
1.7
0.14
18
168
(3025018) Bordetella pertussis Ab [Titer] in Serum
22
158
1.39
0.74
1.1
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
7
38
1.84
0.73
1.0
1.2
umol/24h
1.5
1.7
—
7
38
(3010375) cycloSPORINE [Mass/volume] in Blood
8
132
0.61
0.73
40.4
25.6
ug/l
96.3
111.4
—
8
105
(3016502) Oxygen saturation in Arterial blood
363
3381
1.08
0.73
5.0
7.4
%
95.5
95.6
0.03
345
3253
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
77
653
1.18
0.73
1.3
1.3
miu/ml
145.6
214.4
1.35
30
288
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
8
136
0.59
0.72
7.6
11.6
mmol/l
0.6
0.6
—
8
124
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
5
25
2.00
0.72
1.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
7
39
1.80
0.72
1.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
22
159
1.39
0.72
1.2
1.3
nmol/l
135.9
135.0
0.03
22
159
(3023419) Bacteria identified in Sputum by Culture
53
434
1.22
0.72
2.4
2.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
117
1027
1.14
0.72
4.0
3.8
mmol/l
3.9
3.9
0.39
112
963
(40758558) Short blood count panel - Blood
855
8198
1.06
0.71
5.9
6.8
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
49
398
1.23
0.71
1.4
1.5
%
50.3
60.8
0.88
27
245
(3003888) Timothy IgE Ab [Units/volume] in Serum
44
353
1.25
0.71
1.0
1.1
u/ml
4.9
3.4
0.33
17
166
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
59
708
0.83
0.71
1.7
1.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
125
1103
1.14
0.71
1.8
2.2
ug/l
234.1
683.2
1.58
113
1032
(3051611) Lipemic interference index of Serum or Plasma
45
363
1.24
0.70
2.7
3.5
—
—
—
0
0
(4211845)
22
160
1.38
0.70
4.4
3.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
208
1894
1.10
0.70
1.3
1.4
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
41
1.71
0.70
2.3
2.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
7
41
1.71
0.70
2.3
2.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
106
927
1.15
0.69
1.6
2.5
g/l
0.0
0.0
0.80
94
848
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
70
592
1.19
0.69
6.3
4.8
iu/ml
217.6
611.1
0.92
12
80
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
27
1.85
0.68
1.0
1.7
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
96
835
1.15
0.68
1.4
1.2
titre
232.0
946.1
—
5
28
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
45
365
1.24
0.67
1.1
1.1
u/ml
1.9
3.7
0.77
13
146
(3000012) Reticulocyte production index
23
170
1.36
0.67
1.8
1.5
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
7
121
0.58
0.67
1.6
2.3
e6/l
124.1
924.2
—
7
89
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
21
153
1.37
0.67
1.0
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
85
981
0.86
0.66
1.7
1.7
mg/l
3.1
3.6
0.31
58
712
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
49
403
1.22
0.65
1.1
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
39
483
0.81
0.65
1.1
1.2
u/ml
284.5
285.4
0.01
21
297
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
182
1654
1.11
0.65
1.6
1.7
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
81
701
1.16
0.62
2.0
1.6
mu/l
314.2
313.3
0.01
74
642
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
106
936
1.14
0.62
1.2
1.2
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
36
288
1.25
0.62
1.5
1.9
—
1.3
—
0
12
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
97
852
1.14
0.61
1.2
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
104
0.58
0.61
1.2
2.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
54
452
1.20
0.61
1.2
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
247
2667
0.92
0.61
4.3
7.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
21
156
1.35
0.61
1.2
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
23
301
0.76
0.61
1.1
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2579
25438
1.04
0.60
19.8
18.4
%
13.7
13.8
1.93
2531
24834
(3016650) Hepatitis A virus Ab [Presence] in Serum
57
481
1.19
0.60
1.1
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
17
122
1.40
0.60
2.6
1.9
ug/l
18.5
19.9
0.18
17
109
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
11
72
1.53
0.59
1.5
2.9
—
—
—
0
0
(3036489) Thrombin time
124
1111
1.12
0.59
2.0
2.0
s
21.0
21.5
0.57
106
964
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
28
219
1.28
0.58
2.1
1.9
—
—
—
0
0
(3025315) Body weight
0
23
0.00
0.58
0.0
4.9
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
32
255
1.26
0.58
1.1
1.1
u/ml
5.1
3.0
0.20
12
101
(3052851) Hemolysis interference index of Serum or Plasma
112
1000
1.12
0.57
2.7
3.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
86
755
1.14
0.56
1.2
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
266
2480
1.08
0.56
2.9
2.9
kpa
4.5
4.6
0.44
261
2395
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
20
150
1.34
0.55
1.1
1.6
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
120
1078
1.12
0.55
2.9
3.4
ratio
1.9
1.4
0.28
13
87
(4034850)
118
1059
1.12
0.55
8.9
10.7
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
10
65
1.54
0.55
4.0
2.6
—
—
—
0
0
(4133840)
10
65
1.54
0.55
1.3
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
103
917
1.13
0.55
1.7
2.5
g/l
0.0
0.0
0.00
94
847
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
89
785
1.14
0.55
1.8
1.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
39
321
1.22
0.54
3.7
3.9
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
848
8192
1.05
0.54
3.8
3.8
%
90.3
89.8
0.27
827
7974
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
22
283
0.78
0.53
1.4
1.3
nmol/l
1.4
1.5
0.19
22
255
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
13
91
1.43
0.53
1.2
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
26
327
0.79
0.52
1.2
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
97
864
1.13
0.52
1.9
1.7
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
10
66
1.52
0.52
1.1
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
46
387
1.19
0.52
1.3
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
16
117
1.37
0.52
1.8
1.9
ug/l
51.7
57.6
0.26
16
112
(21494755) Public health laboratory ask at order entry panel
223
2073
1.08
0.52
1.4
1.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
98
0.61
0.52
2.0
2.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
98
0.61
0.52
2.0
2.7
—
—
—
0
0
(4015189)
12
83
1.45
0.51
2.0
2.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
9
64
1.41
0.51
1.9
1.8
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
45
379
1.19
0.51
1.6
1.7
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
9
65
1.39
0.50
1.8
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
287
2699
1.07
0.49
4.6
4.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
17
127
1.34
0.49
1.1
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
44
519
0.85
0.49
1.1
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
99
889
1.12
0.48
5.9
4.5
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
7
46
1.52
0.48
1.1
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
21
163
1.29
0.48
5.2
13.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
98
880
1.12
0.48
1.2
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
164
1512
1.09
0.48
1.6
1.7
g/l
1.6
1.5
0.23
140
1295
(3010726) Horse dander IgE Ab [Units/volume] in Serum
38
318
1.20
0.47
1.1
1.1
u/ml
2.0
1.9
—
9
81
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
102
920
1.11
0.46
1.6
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
27
218
1.24
0.46
1.1
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
25
309
0.81
0.45
1.4
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
93
836
1.12
0.45
3.3
3.6
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
77
1.43
0.45
1.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
7
50
1.40
0.45
1.0
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
22
174
1.27
0.44
1.1
1.2
ratio
1.0
1.0
—
7
58
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
25
308
0.81
0.44
1.4
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
7
51
1.37
0.44
1.1
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
34
284
1.20
0.43
1.4
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
25
307
0.81
0.43
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
25
307
0.81
0.43
1.4
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
46
533
0.86
0.43
1.2
1.3
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
11
78
1.41
0.43
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
11
78
1.41
0.43
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
11
78
1.41
0.43
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
11
78
1.41
0.43
1.2
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
31
1.61
0.43
1.0
1.4
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
31
1.61
0.43
1.2
1.2
—
—
—
0
0
(3019174) dRVVT (LA screen)
5
32
1.56
0.42
1.2
1.2
—
—
—
0
0
(3036603) Volume of Urine
26
212
1.23
0.42
1.5
1.4
ml
1921.4
1846.3
—
8
41
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
24
194
1.24
0.42
1.3
1.2
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
5
33
1.52
0.41
13.6
13.8
—
—
—
0
0
(3013762) Body weight Measured
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
34
1.47
0.40
1.0
2.6
u/field
0.6
0.8
—
5
34
(3036525) Urea [Moles/time] in 24 hour Urine
0
18
0.00
0.40
0.0
3.6
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
18
0.00
0.40
0.0
1.3
—
4774.7
—
0
11
(3036782) Glucose [Moles/volume] in Pleural fluid
27
325
0.83
0.40
1.3
1.4
mmol/l
6.3
6.4
0.17
27
303
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
26
314
0.83
0.39
1.4
1.2
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
19
0.00
0.39
0.0
1.5
—
23.6
—
0
10
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
16
124
1.29
0.38
1.2
1.5
umol/l
33.4
30.7
0.50
16
119
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
27
224
1.21
0.38
1.1
1.0
mg/l
290.0
291.3
0.04
27
200
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
17
214
0.79
0.37
2.0
1.5
g/l
0.9
1.0
0.85
17
214
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
45
514
0.87
0.37
1.2
1.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
52
459
1.13
0.36
2.5
2.5
u/ml
272.0
1801.0
—
5
29
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
33
281
1.18
0.36
1.5
1.6
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
9
71
1.27
0.36
1.1
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
9
71
1.27
0.36
1.3
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
145
1554
0.93
0.36
1.5
1.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
12
90
1.33
0.35
1.3
1.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
17
135
1.26
0.35
1.5
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
72
651
1.11
0.35
3.9
3.7
%
56.2
57.6
0.38
72
651
(3011648) Oxygen content in Venous blood
20
244
0.82
0.34
1.2
2.0
%
10.5
10.9
0.21
20
244
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
28
236
1.19
0.34
1.4
1.5
u/l
12.6
13.5
0.39
28
226
(40758292) HTLV I+II Ab panel - Serum
6
44
1.36
0.34
1.3
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
33
283
1.17
0.34
1.1
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
45
1.33
0.33
1.0
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
65
586
1.11
0.33
1.2
1.6
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
6
46
1.30
0.33
1.2
1.5
%
73.3
76.5
—
6
40
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
47
1.28
0.32
1.7
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
70
769
0.91
0.32
1.3
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
24
284
0.84
0.31
1.2
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
23
273
0.84
0.31
2.3
2.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
25
211
1.19
0.31
1.6
1.8
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
7
97
0.72
0.30
1.6
2.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
53
1.32
0.30
1.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
34
296
1.15
0.30
1.1
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
195
1851
1.06
0.30
1.7
1.8
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
139
1479
0.94
0.30
2.1
3.7
mmol/l
23.8
24.2
0.93
125
1318
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
14
111
1.26
0.30
1.5
1.7
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
326
3136
1.04
0.30
5.4
7.8
g/l
123.6
120.3
2.45
312
3021
(3035320) C reactive protein [Mass/volume] in Body fluid
27
231
1.17
0.29
2.2
2.5
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
274
2857
0.96
0.29
4.0
6.4
mmol/l
1.3
1.4
0.03
264
2755
(3000475) Leukocytes [#/volume] in Synovial fluid
87
804
1.08
0.29
1.5
1.6
e6/l
8122.6
13932.6
1.23
65
579
(21494814) CD8 cells/100 lymphocytes in Specimen
15
121
1.24
0.28
1.4
1.8
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
10
76
1.32
0.28
1.1
1.9
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
46
412
1.12
0.28
1.2
1.9
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
19
158
1.20
0.28
4.6
3.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
83
767
1.08
0.28
3.2
3.2
nmol/l
0.9
0.8
0.30
67
583
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
28
242
1.16
0.28
1.1
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
122
1145
1.07
0.28
2.6
3.0
u/ml
0.4
0.4
0.24
75
664
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
37
327
1.13
0.27
1.7
1.5
nmol/l
0.3
0.3
0.14
24
238
(3008401) Mugwort IgE Ab [Units/volume] in Serum
39
346
1.13
0.27
1.0
1.1
u/ml
0.6
1.3
0.66
13
143
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
32
280
1.14
0.27
1.9
1.9
mg/l
3.1
4.4
2.17
32
271
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
8
64
1.25
0.27
4.1
7.8
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
117
0.77
0.27
1.0
1.0
—
—
—
0
0
(3010421) pH of Blood
95
884
1.08
0.27
3.3
4.2
ph
7.4
7.4
0.16
87
736
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
26
224
1.16
0.27
1.3
1.6
u/l
5.1
6.5
—
9
112
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
15
122
1.23
0.27
2.4
2.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
182
1733
1.05
0.26
4.3
3.6
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
46
414
1.11
0.26
1.3
1.5
e6/l
2239.6
2094.2
0.09
39
314
(44790048)
32
363
0.88
0.26
1.9
1.4
—
—
—
0
0
(44806118)
32
363
0.88
0.26
1.9
1.4
—
—
—
0
0
(44790047)
32
363
0.88
0.26
1.9
1.4
—
—
—
0
0
(44790049)
32
363
0.88
0.26
1.9
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
42
468
0.90
0.26
1.2
1.4
u/ml
109.7
124.1
—
10
95
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
8
67
1.19
0.26
2.8
2.3
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
8
67
1.19
0.26
3.6
6.5
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
12
95
1.26
0.26
1.2
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
54
593
0.91
0.26
1.3
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
160
1.19
0.25
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
54
492
1.10
0.25
1.1
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
15
181
0.83
0.25
2.0
2.7
ph
7.4
7.4
—
8
61
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
9
75
1.20
0.25
1.2
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
9
75
1.20
0.25
3.2
1.5
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
9
77
1.17
0.24
1.0
1.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
9
77
1.17
0.24
1.1
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
15
180
0.83
0.24
1.7
1.8
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
82
0.73
0.24
1.0
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
41
454
0.90
0.24
1.2
1.2
u/ml
1.3
3.9
2.10
16
144
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
5
38
1.32
0.23
1.8
1.4
nmol/l
3.3
858071.9
—
5
31
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
13
106
1.23
0.23
1.2
1.4
mmol/l
3.7
3.1
0.42
13
96
(3016038) Potassium [Moles/volume] in Urine
26
228
1.14
0.22
1.0
1.1
mmol/l
27.9
35.1
1.03
21
194
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
183
1753
1.05
0.22
6.3
10.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
84
786
1.07
0.22
2.3
2.9
mg/l
1.4
1.6
2.32
76
709
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
165
1726
0.95
0.22
4.6
8.7
mmol/l
24.5
24.4
0.21
148
1601
(44806071)
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
7
93
0.75
0.22
1.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
23
263
0.87
0.22
1.1
1.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
297
2877
1.04
0.22
5.4
7.1
mmol/l
9.3
10.3
1.75
273
2738
(40760410) HLA-B [Type] by High resolution
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
1.7
—
0
10
(3013862) HLA-DP [Type]
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
23
262
0.88
0.21
1.1
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
23
201
1.15
0.21
1.2
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
23
201
1.15
0.21
1.5
1.6
—
—
—
0
0
(37019676) Renin [Units/volume] in Plasma --supine
0
13
0.00
0.21
0.0
1.1
—
12.4
—
0
6
(3028300) Cannabinoids [Presence] in Urine
50
543
0.92
0.20
1.3
1.9
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
14
0.00
0.20
0.0
1.2
—
2.4
—
0
14
(3042517) Benzodiazepines panel - Urine
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
56
520
1.08
0.19
1.3
1.4
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
14
118
1.19
0.19
1.0
1.1
u/ml
0.4
1.0
—
5
41
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
49
453
1.08
0.18
1.3
1.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
14
164
0.85
0.18
1.1
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
31
342
0.91
0.18
1.3
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
50
538
0.93
0.17
1.3
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
50
538
0.93
0.17
1.3
2.0
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
33
300
1.10
0.17
1.1
1.1
nmol/l
324.5
366.7
0.48
24
252
(40768793) Breast Pathology biopsy report
80
846
0.94
0.17
1.3
1.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
76
717
1.06
0.17
2.6
3.2
u/ml
1162.9
870.8
0.10
68
657
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
42
387
1.09
0.17
1.7
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
24
214
1.12
0.17
1.7
1.6
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
45
417
1.08
0.16
1.2
1.1
au/ml
12.2
13.1
—
5
15
(3045788) Cell count panel - Pleural fluid
36
330
1.09
0.16
1.5
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
333
3409
0.97
0.16
1.4
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
13
111
1.17
0.15
1.3
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
77
0.78
0.15
1.8
1.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
80
0.75
0.15
1.2
1.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
9
79
1.14
0.15
1.2
1.1
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
9
80
1.13
0.15
1.4
2.0
mmol/l
1.9
1.5
—
9
74
(3028308) Erythrocytes [#/volume] in Pleural fluid
40
371
1.08
0.15
1.3
1.5
e6/l
93553.0
73136.4
0.15
27
226
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
83
1.08
0.14
1.0
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
83
1.08
0.14
1.1
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
46
430
1.07
0.14
1.1
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
11
93
1.18
0.14
1.4
1.5
ug/l
8.3
8.9
0.36
11
93
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
62
586
1.06
0.14
1.6
1.4
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
20
179
1.12
0.14
2.3
2.1
—
172.9
—
0
37
(3014051) Protein [Presence] in Urine by Test strip
81
773
1.05
0.14
2.3
2.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
84
1.19
0.14
1.2
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
86
899
0.96
0.14
2.4
2.1
%
95.9
90.9
1.36
80
842
(3028707) Methadone [Presence] in Urine by Screen method
22
243
0.90
0.13
1.4
2.4
—
—
—
0
0
(3035880) pH of Pleural fluid
18
201
0.90
0.13
1.3
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
51
540
0.94
0.13
1.3
2.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
49
462
1.06
0.12
1.1
1.1
iu/ml
1.1
1368.5
—
9
96
(44816559) Phosphatidylethanol [Mass/volume] in Blood
45
478
0.94
0.12
1.6
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
19
171
1.11
0.12
3.1
3.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
40
375
1.07
0.12
1.2
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
41
436
0.94
0.12
1.1
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
31
288
1.08
0.11
1.4
2.1
u/field
4.8
2.0
0.55
12
104
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
79
823
0.96
0.11
1.7
1.5
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
21
230
0.91
0.11
1.0
1.2
—
127.1
—
0
7
(3035947) Staphylolysin Ab [Units/volume] in Serum
16
143
1.12
0.11
1.1
1.1
iu/ml
—
4.0
—
0
6
(3002523) Influenza virus A Ag [Presence] in Specimen
40
376
1.06
0.11
1.2
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
34
318
1.07
0.11
1.3
1.4
e6/l
29467.2
90636.2
0.86
18
223
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
12
105
1.14
0.11
1.1
1.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
27
291
0.93
0.11
3.0
2.9
mg/l
36.4
33.6
0.03
19
208
(3045142) Bone marrow Pathology biopsy report
40
377
1.06
0.10
1.1
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
42
444
0.95
0.10
1.2
1.2
u/ml
2.9
4.9
1.38
22
182
(3013005) Retinol [Moles/volume] in Serum or Plasma
13
115
1.13
0.10
1.2
1.5
umol/l
2.2
2.1
0.16
13
106
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
100
1033
0.97
0.10
1.3
1.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
58
606
0.96
0.10
1.6
1.8
nmol/l
1.1
0.8
0.60
45
497
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
45
1.11
0.09
1.0
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
45
1.11
0.09
4.0
8.0
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
25
232
1.08
0.09
1.4
2.0
%
30.4
44.7
—
5
20
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
5
46
1.09
0.09
1.2
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
51
533
0.96
0.09
1.3
1.9
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
11
97
1.13
0.09
1.0
1.1
—
0.4
—
0
18
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
82
847
0.97
0.09
2.5
2.5
g/l
3.7
3.6
0.21
77
796
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
58
1.03
0.08
3.7
7.9
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
72
696
1.04
0.08
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
72
696
1.04
0.08
1.3
1.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
60
0.83
0.08
1.4
1.4
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
60
0.83
0.08
1.8
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
62
0.81
0.08
2.2
1.8
—
—
—
0
0
(4198724)
7
68
1.03
0.07
1.1
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
38
362
1.05
0.07
1.4
2.8
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
71
0.84
0.07
4.2
4.9
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
11
98
1.12
0.07
1.0
1.1
miu/ml
1433.2
1658.2
0.24
11
98
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
19
176
1.08
0.07
1.6
1.7
ug/l
2.9
4.7
0.44
12
140
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
15
137
1.10
0.07
1.3
1.5
pmol/l
85.5
245.6
—
6
50
(3024928) Oxygen saturation in Venous blood
62
641
0.97
0.07
1.5
2.8
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
7
83
0.84
0.07
1.1
1.2
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
9
85
1.06
0.07
1.1
1.4
%
19.9
22.0
—
9
71
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
349
3451
1.01
0.07
3.4
3.6
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
9
88
1.02
0.07
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
88
1.02
0.07
1.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
49
472
1.04
0.06
1.8
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
92
0.87
0.06
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
8
92
0.87
0.06
1.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
34
356
0.95
0.06
1.5
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
296
2926
1.01
0.06
1.5
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
55
532
1.03
0.06
1.3
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
79
770
1.03
0.06
1.9
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
25
264
0.95
0.06
1.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
12
109
1.10
0.06
1.4
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
48
464
1.03
0.05
1.4
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
48
464
1.03
0.05
2.4
2.8
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
288
2850
1.01
0.05
4.2
3.8
mmol/l
1.2
1.2
0.38
247
2470
(40768446) Kidney Pathology biopsy report
10
110
0.91
0.05
1.3
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
16
171
0.94
0.05
1.5
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
16
171
0.94
0.05
1.5
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
23
242
0.95
0.05
2.7
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1010
10139
0.99
0.04
3.1
3.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
30
312
0.96
0.04
1.3
1.4
%
29.5
29.5
0.00
15
191
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
17
160
1.06
0.04
1.0
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
21
200
1.05
0.03
1.5
1.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
13
121
1.07
0.03
1.0
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
24
230
1.04
0.03
1.2
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
16
151
1.06
0.03
3.3
2.6
u/ml
617.8
1112.6
1.58
16
151
(3010838) Calcium [Moles/time] in 24 hour Urine
17
179
0.95
0.03
1.5
1.8
—
9.2
—
0
10
(3048929) Epstein Barr virus Ab [Presence] in Serum
73
718
1.02
0.03
1.1
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
133
1316
1.01
0.03
1.6
1.8
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
12
112
1.07
0.03
2.4
1.3
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
35
341
1.03
0.02
1.6
1.4
mosm/kgh2o
271.7
276.1
0.48
27
263
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
316
3146
1.00
0.02
2.0
2.1
g/l
0.2
0.2
1.63
298
2931
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
127
1259
1.01
0.02
3.0
3.3
u/ml
108.1
3535.1
0.90
111
1056
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
28
272
1.03
0.02
1.0
1.0
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
10
107
0.93
0.02
1.3
1.6
%
2.4
2.8
—
10
88
(3014576) Chloride [Moles/volume] in Serum or Plasma
413
4143
1.00
0.01
4.9
6.5
mmol/l
104.1
104.2
0.23
405
4048
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
29
297
0.98
0.01
1.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
35
343
1.02
0.01
1.1
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
98
988
0.99
0.01
1.9
1.7
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
18
174
1.03
0.00
3.4
2.7
%
55.5
39.9
—
8
58
(3004451) EKG impression Narrative
18
174
1.03
0.00
1.2
1.3
—
—
—
0
0
(3016750) Collection duration of Urine
20
194
1.03
0.00
2.0
2.0
min
520.3
494.9
0.47
14
142
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
47
464
1.01
0.00
1.8
1.5
—
—
—
0
0
(4035726)
306
3054
1.00
0.00
1.4
1.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
21
208
1.01
0.00
1.1
1.4
promille
1.3
1.2
0.17
14
158
(3034426) Prothrombin time (PT)
10
105
0.95
0.00
1.2
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
35
352
0.99
0.00
1.6
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
225
1.02
0.00
1.5
1.5
—
—
—
0
0
(4306422)
43
435
0.99
0.00
1.2
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
49
495
0.99
0.00
1.3
2.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
391
3915
1.00
0.00
1.5
1.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
10
101
0.99
0.00
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
15
149
1.01
0.00
1.0
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
26
261
1.00
0.00
2.0
2.2
ml
722.9
636.5
0.30
17
169
(4268621)
31
309
1.00
0.00
2.2
2.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
82
824
1.00
0.00
3.0
2.4
%
183.0
195.9
0.68
75
782
(3023183) Ammonium ion [Moles/volume] in Plasma
65
654
0.99
0.00
2.3
2.7
umol/l
35.7
35.4
0.03
59
545
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
30
304
0.99
0.00
1.3
1.4
u/l
396.5
307.3
0.49
30
294
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
62
616
1.01
0.00
2.4
2.9
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
10
103
0.97
0.00
1.0
1.2
—
—
—
0
0
(44806420)
11
107
1.03
0.00
2.2
2.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
127
1.02
0.00
1.7
2.6
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
13
127
1.02
0.00
1.2
1.6
%
68.2
65.9
0.10
13
101
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
98
0.92
0.00
1.1
1.2
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
58
0.86
0.00
1.8
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
8
86
0.93
0.00
1.3
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
38
380
1.00
0.00
1.9
1.6
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
98
0.92
0.00
2.4
1.3
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
6
0.00
0.00
0.0
7.3
—
70.5
—
0
6
(3024932) HLA-DR beta [Type]
7
75
0.93
0.00
1.0
1.1
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
1.5
—
3513.3
—
0
6
(3043410) Blood group antigens tested for on Red Blood Cells
9
92
0.98
0.00
1.0
1.9
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
1.3
—
0
6
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
1.2
—
154.8
—
0
6
(3002331) Protein [Mass/volume] in Peritoneal fluid
7
75
0.93
0.00
1.0
1.5
g/l
22.3
25.8
—
7
60
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
6
0.00
0.00
0.0
5.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
40
400
1.00
0.00
1.8
1.7
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
17
170
1.00
0.00
3.1
4.1
—
—
—
0
0
(3024471) HLA-A [Type]
7
77
0.91
0.00
1.0
1.0
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
153.9
—
0
5
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
25.8
—
0
5
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
9
0.00
0.00
0.0
5.0
—
378.4
—
0
9
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
9
98
0.92
0.00
1.4
1.5
%
10.6
24.2
—
9
89

Mortality – FinRegistry

↥

Association

Association between endpoint H8_MENIERE and mortality.

Females

Parameter HR [95% CI] p-value
H8_MENIERE 0.876 [0.8, 0.96] 0.006
Birth year 0.991 [0.98, 1.0] 0.033

During the follow-up period (1.1.1998 — 31.12.2019), 1902 out of 13148 females with H8_MENIERE died.

Males

Parameter HR [95% CI] p-value
H8_MENIERE 0.777 [0.71, 0.85] < 0.001
Birth year 0.988 [0.98, 1.0] 0.01

During the follow-up period (1.1.1998 — 31.12.2019), 1269 out of 7015 males with H8_MENIERE died.

Mortality risk

Mortality risk for people of age

years, who have H8_MENIERE.

N-year risk Females Males
1 0.092% 0.158%
5 0.431% 0.937%
10 1.069% 2.318%
15 2.118% 4.412%
20 3.919% 7.457%

Relationships between endpoints

↥

Index endpoint: H8_MENIERE – Ménière disease

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data